- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Saxagliptin with dapagliflozin – July 2017
Saxagliptin with dapagliflozin: Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg; Qtern®
Last updated
10 November 2017